52.1 F
Fort Worth
Saturday, November 28, 2020
Health Care CVS Health picks Lynch to lead as CEO starting in February

CVS Health picks Lynch to lead as CEO starting in February

Other News

Venezuela judge convicts 6 American oil execs, orders prison

By SCOTT SMITH ASSOCIATED PRESSCARACAS, Venezuela (AP) — Six American oil executives held for three years in Venezuela were found guilty of corruption charges...

Cowboys miss chance for NFC East lead with another home loss

ARLINGTON, Texas (AP) — Both starting offensive tackles were lost to injury on their first drive of the game, Ezekiel Elliott lost another fumble...

JRB Fort Worth chosen for main operating base for C-130J aircraft

Naval Air Station Joint Reserve Base Fort Worth has been selected as a main operating base for eight C-130J aircraft at the 136th Airlift...

Commentary: When to donate rewards to charity and when to give cash

By ERIN HURD of NerdWalletIf you're looking to give to charity this holiday season but don't want to dip into your bank account, donating...


By TOM MURPHY AP Health Writer

CVS Health has chosen a veteran insurance executive as its new top executive with the company shifting more toward helping customers stay healthy and dealing with the COVID-19 pandemic.
The drugstore chain and pharmacy benefit manager said Friday that Karen Lynch will replace Larry Merlo as president and CEO on Feb. 1. She also will join the company’s board of directors.
The company also reported a better-than-expected third quarter and raised its 2020 forecast. CVS Health shares then jumped in morning trading.

The 64-year-old Merlo has led the company for a decade. He oversaw the company’s roughly $69-billion acquisition of the insurer Aetna, a deal completed in 2018.
Merlo, who began his career as a pharmacist, guided the company through a big change a few years ago when CVS stopped selling tobacco products and took a revenue hit because of it.
More recently, CVS health has started opening stores it calls “HealthHubs” that have dietitians and are geared toward helping customers monitor chronic conditions like diabetes and stay on top of their health.

On the pandemic front, CVS Health has administered more than 5 million COVID-19 tests, and Merlo told analysts Friday that the company expects to play a big role in doling out vaccines once they become available.
Merlo said Lynch has a “deep understanding” of the company’s strategy and has been a key leader during the evolution of CVS Health in recent years.
Lynch, 57, is the president of the company’s Aetna insurance division. She came to CVS Health as part of the Aetna deal and served as an executive with another insurer, Cigna, before that.

Investors will likely react positively to the leadership change due to Lynch’s experience in health care, Mizuho Securities analyst Ann Hynes said.
In the third quarter, revenue at CVS climbed more than 3% to $67.1 billion, and adjusted earnings were $1.66 per share.
Both topped expectations on Wall Street. Analysts forecast, on average, earnings of $1.33 per share on $66.62 billion in revenue, according to FactSet.
Net income dropped 20% to $1.22 billion, mainly due to the early retirement of some debt.
The pandemic hit drugstores hard earlier this year when the economy shutdown and customers stayed home. But there are now signs of a recovery.

CVS Health filled more prescriptions in the third quarter even though the number of new prescriptions is down due to the pandemic, which is still keeping some patients away from the doctor’s office.
Operating income grew nearly 17% for the company’s pharmacy benefit management business but fell on the health insurance side, due partly to pandemic-related costs.
CVS Health now expects adjusted per-share earnings of between $7.35 and $7.45. That’s up from a previous forecast for $7.14 to $7.27 per share.
For the full year, analysts project, on average, earnings of $7.23 per share.

CVS Health Corp., based in Woonsocket, Rhode Island, runs one of the nation’s largest drugstore chains with about 9,900 retail locations. In addition to selling insurance, it also runs prescription drug plans for big clients like insurers and employers through a large pharmacy benefit management business.
Company shares climbed more than 5% to $64.62.
The stock has fallen 17% this year.


Follow Tom Murphy on Twitter: @thpmurphy

close

Oh hi there 👋
It’s nice to meet you.

Sign up to receive awesome content in your inbox.

We don’t spam! Read our privacy policy for more info.

Latest News

3rd major COVID-19 vaccine shown to be effective and cheaper

By DANICA KIRKA Associated PressLONDON (AP) — Drugmaker AstraZeneca said Monday that late-stage trials showed its COVID-19 vaccine is highly effective, buoying the prospects...

These health care workers will be first in line for a COVID-19 vaccine

Health care workers will be the first people in Texas to receive a COVID-19 vaccine once one receives emergency approval from the U.S. government,...

Tarrant County reports 1,537 new COVID cases on Sunday and 6 deaths

Tarrant County Public Health reported 1,537 new cases on Sunday, Nov. 22 and six deaths. “It took 90 days to reach 10,000 cases in June....

Employers start sending workers shopping for health coverage

Instead of offering one or more options, some companies are turning health insurance shopping over to employees. A federal rule change last year stoked this...

Abbott appoints Michael Coble to Texas Forensic Science Commission

Gov. Greg Abbott has appointed Michael Coble, Ph.D. to the Texas Forensic Science Commission for a term set to expire on Sept. 1, 2021. The...